Immunoglobulin G expression in carcinomas and cancer cell lines

FASEB Journal

Volumn 21, Issue 11, 2007, Pages 2931-2938

  Chen, Zhengshan ^a   Gu, Jiang ^a  

^a PEKING UNIVERSITY HEALTH SCIENCE CENTER   (China)

Author keywords

In situ hybridization; Laser microdissection

Indexed keywords

IMMUNOGLOBULIN G; IMMUNOGLOBULIN G1;

ARTICLE; B LYMPHOCYTE; CANCER CELL CULTURE; CARCINOMA CELL; CONTROLLED STUDY; GENE EXPRESSION; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; IMMUNOGLOBULIN PRODUCTION; IMMUNOHISTOCHEMISTRY; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ADENOCARCINOMA; BLOTTING, WESTERN; CELL LINE, TUMOR; DNA-BINDING PROTEINS; ELECTROPHORESIS, POLYACRYLAMIDE GEL; FLOW CYTOMETRY; FLUORESCENT ANTIBODY TECHNIQUE; GENES, IMMUNOGLOBULIN HEAVY CHAIN; HOMEODOMAIN PROTEINS; HUMANS; IMMUNOGLOBULIN G; IN SITU HYBRIDIZATION; LASERS; MICRODISSECTION; NEOPLASMS; NUCLEAR PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA PROBES;

EID: 34548492482     PISSN: 08926638     EISSN: None     Source Type: Journal    
DOI: 10.1096/fj.07-8073com     Document Type: Article

References (36)

1. Kimoto, Y. (1998) Expression of heavy-chain constant region of immunoglobulin and T-cell receptor gene transcripts in human non-hematopoietic tumor cell lines. Genes Chromosomes Cancer. 22, 83-86
2. Qiu, X., Zhu, X., Zhang, L., Mao, Y., Zhang, J., Hao, P., Li, G., Lv, P., Li, Z., Sun, X., et al. (2003) Human epithelial cancers secrete immunoglobulin g with unidentified specificity to promote growth and survival of tumor cells. Cancer Res. 63, 6488-6495
3. Babbage, G., Ottensmeier, C. H., Blaydes, J., Stevenson, F. K., and Sahota, S. S. (2006) Immunoglobulin heavy chain locus events and expression of activation-induced cytidine deaminase in epithelial breast cancer cell lines. Cancer Res. 66, 3996-4000
4. Liu, H. D., Zheng, H., Li, M., Hu, D. S., Tang, M., and Cao, Y. (2007) Upregulated expression of kappa light chain by Epstein-Barr virus encoded latent membrane protein 1 in nasopharyngeal carcinoma cells via NF-kappaB and AP-1 pathways. Cell Signal. 19, 419-427
5. Maizels, N. (2005) Immunoglobulin gene diversification. Annu. Rev. Genet. 39, 23-46
6. Bassing, C. H., Swat, W., and Alt, F. W. (2002) The mechanism and regulation of chromosomal V(D)J recombination. Cell 109 Suppl, S45-S55
7. Gellert, M. (2002) V(D)J recombination: RAG proteins, repair factors, and regulation. Annu. Rev. Biochem. 71, 101-132
8. Gellert, M. (1997) Recent advances in understanding V(D)J recombination. Adv. Immunol. 64, 39-64
9. Oettinger, M. A. (1999) V(D)J recombination: on the cutting edge. Curr. Opin. Cell Biol. 11, 325-329
10. Jacob, J., Kelsoe, G., Rajewsky, K., and Weiss, U. (1991) Intraclonal generation of antibody mutants in germinal centres. Nature. 354, 389-392
11. Liu, Y. J., Malisan, F., de Bouteiller, O., Guret, C., Lebecque, S., Banchereau, J., Mills, F. C., Max, E. E., and Martinez-Valdez, H. (1996) Within germinal centers, isotype switching of immunoglobulin genes occurs after the onset of somatic mutation. Immunity. 4, 241-250
12. Muramatsu, M., Sankaranand, V. S., Anant, S., Sugai, M., Kinoshita, K., Davidson, N. O., and Honjo, T. (1999) Specific expression of activation-induced cytidine deaminase (AID), a novel member of the RNA-editing deaminase family in germinal center B cells. J. Biol. Chem. 274, 18470-18476
13. Revy, P., Muto, T., Levy, Y., Geissmann, F., Plebani, A., Sanal, O., Catalan, N., Forveille, M., Dufourcq-Labelouse, R., Gennery, A., et al. (2000) Activation-induced cytidine deaminase (AID) deficiency causes the autosomal recessive form of the Hyper-IgM syndrome (HIGM2). Cell. 102, 565-575
14. Muramatsu, M., Kinoshita, K., Fagarasan, S., Yamada, S., Shinkai, Y., and Honjo, T. (2000) Class switch recombination and hypermutation require activation-induced cytidine deaminase (AID), a potential RNA editing enzyme. Cell. 102, 553-563
15. Petersen, S., Casellas, R., Reina-San-Martin, B., Chen, H. T., Difilippantonio, M. J., Wilson, P. C., Hanitsch, L., Celeste, A., Muramatsu, M., Pilch, D. R., et al. (2001) AID is required to initiate Nbs1/gamma-H2AX focus formation and mutations at sites of class switching. Nature. 414, 660-665
16. Okazaki, I. M., Kinoshita, K., Muramatsu, M., Yoshikawa, K., and Honjo, T. (2002) The AID enzyme induces class switch recombination in fibroblasts. Nature. 416, 340-345
17. Petersen-Mahrt, S. K., Harris, R. S., and Neuberger, M. S. (2002) AID mutates E. coli suggesting a DNA deamination mechanism for antibody diversification. Nature 418, 99-103
18. Yoshikawa, K., Okazaki, I. M., Eto, T., Kinoshita, K., Muramatsu, M., Nagaoka, H., and Honjo, T. (2002) AID enzyme-induced hypermutation in an actively transcribed gene in fibroblasts. Science 296, 2033-2036
19. Snapper, C. M., Marcu, K. B., and Zelazowski, P. (1997) The immunoglobulin class switch: beyond "accessibility". Immunity 6, 217-223
20. Iwasato, T., Shimizu, A., Honjo, T., and Yamagishi, H. (1990) Circular DNA is excised by immunoglobulin class switch recombination. Cell. 62, 143-149
21. Goebel, P., Janney, N., Valenzuela, J. R., Romanow, W. J., Murre, C., and Feeney, A. J. (2001) Localized gene-specific induction of accessibility to V(D)J recombination induced by E2A and early B cell factor in nonlymphoid cells. J. Exp. Med. 194, 645-656
22. Cerutti, A., Zan, H., Schaffer, A., Bergsagel, L., Harindranath, N., Max, E. E., and Casali, P. (1998) CD40 ligand and appropriate cytokines induce switching to IgG, IgA, and IgE and coordinated germinal center and plasmacytoid phenotypic differentiation in a human monoclonal IgM+IgD+ B cell line. J. Immunol. 160, 2145-2157
23. Cerutti, A., Zan, H., Kim, E. C., Shah, S., Schattner, E. J., Schaffer, A., and Casali, P. (2002) Ongoing in vivo immunoglobulin class switch DNA recombination in chronic lymphocytic leukemia B cells. J. Immunol. 169, 6594-6603
24. Lynch, S., Kelleher, D., McManus, R., and O'Farrelly, C. (1995) RAG1 and RAG2 expression in human intestinal epithelium: evidence of extrathymic T cell differentiation. Eur. J. Immunol. 25, 1143-1147
25. Schreiber, H., Wu, T. H., Nachman, J., and Rowley, D. A. (2000) Immunological enhancement of primary tumor development and its prevention. Semin. Cancer Biol. 10, 351-357
26. Prehn, R. T. (1994) Stimulatory effects of immune reactions upon the growths of untransplanted tumors. Cancer Res. 54, 908-914
27. Prehn, R. T. (1996) The paradoxical association of regression with a poor prognosis in melanoma contrasted with a good prognosis in keratoacanthoma. Cancer Res. 56, 937-940
28. Snell, G. D. (1957) Incompatibility reactions to tumor homotransplants with particular reference to the role of the tumor; a review. Cancer Res. 17, 2-10
29. Kaliss, N. (1958) Immunological enhancement of tumor homografts in mice: a review. Cancer Res. 18, 992-1003
30. Manson, L. A. (1994) Anti-tumor immune responses of the tumor-bearing host: the case for antibody-mediated immunologic enhancement. Clin. Immunol. Immunopathol. 72, 1-8
31. Hellstrom, I., Hellstrom, K. E., Evans, C. A., Heppner, G. H., Pierce, G. E., and Yang, J. P. (1969) Serum-mediated protection of neoplastic cells from inhibition by lymphocytes immune to their tumor-specific antigens. Proc. Natl. Acad. Sci. U. S. A. 62, 362-368
32. Sjogren, H. O., Hellstrom, I., Bansal, S. C., and Hellstrom, K. E. (1971) Suggestive evidence that the "blocking antibodies" of tumor-bearing individuals may be antigen-antibody complexes. Proc. Natl. Acad. Sci. U. S. A. 68, 1372-1375
33. Gercel-Taylor, C., Bazzett, L. B., and Taylor, D. D. (2001) Presence of aberrant tumor-reactive immunoglobulins in the circulation of patients with ovarian cancer. Gynecol. Oncol. 81, 71-76
34. Zenclussen, A. C., Gentile, T., Kortebani, G., Mazzolli, A., and Margni, R. (2001) Asymmetric antibodies and pregnancy. Am. J. Reprod. Immunol. 45, 289-294
35. Margni, R. A., and Malan Borel, I. (1998) Paradoxical behavior of asymmetric IgG antibodies. Immunol. Rev. 163, 77-87
36. Luborsky, J. L., Barua, A., Shatavi, S. V., Kebede, T., Abramowicz, J., and Rotmensch, J. (2005) Anti-tumor antibodies in ovarian cancer. Am. J. Reprod. Immunol. 54, 55-62